Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/21/2010US7799813 Salts of substituted 5-membered azacycle and use thereof in the treatment of diseases related to protein aging
09/21/2010US7799812 Reverse isoxazoles
09/21/2010US7799811 administering 1-[4-(4-chlorophenyl)-1,2,5-oxadiazol-3-yl]-3-[4-(trifluoromethyl)phenyl]urea, as antiproliferative or anticarcinogenic agents and as antagonists of signal transducers and activators of transcription (STAT) proteins
09/21/2010US7799810 thiazol-2-yl-urea derivatives such as 3-{3-[4-Methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-N-pyridin-3-yl-propionamide, used in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase, particularly inflammatory, allergic or autoimmune conditions
09/21/2010US7799809 N-(3-Amino-1-benzyl-2,3-dioxopropyl)-2-{3-[3-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}nicotinamide; neurodegenerative disorders, chronic brain supply deficit, ischemia (stroke) o brain trauma, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease
09/21/2010US7799808 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
09/21/2010US7799807 vanilloid receptor antagonists comprising phenylene compounds, used as analgesic
09/21/2010US7799806 Somatostatin (SST) receptor subtype 5 antagonists; antidiabetic agents; side effect reduction; reducing or alkylating a carboxyheteroaryl piperidine with an aldehyde, benzyl halide, or tributylphosphine and diethyl azodicarboxylate
09/21/2010US7799805 Piperidine carboxylic acid amide derivatives
09/21/2010US7799804 1,2-diarylimidazole-4-carboxamide compounds such as ethanesulfonic acid 4-[2-(2,4-dichlorophenyl)-5-methyl-4-(piperidin-1-ylcarbamoyl)-imidazol-1-yl]phenyl ester, used in the treatment of obesity, psychological and nervous system disorders
09/21/2010US7799803 Hydroxamic acid compounds and methods of use thereof
09/21/2010US7799802 alleviating depression, comprising administering a purified benzylisoquinoline compound selected from the group consisting of armepavine and O-methylarmepavine
09/21/2010US7799801 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2010US7799800 Lipid-modified immune response modifiers
09/21/2010US7799799 (2-butylindolizin-3-yl){4-[3-(diethylamino)propyl]phenyl}methanone hydrochloride, used as antiarrhythmia, hypotensive and adrenergic blocking agents having improved water soubility and metabolic stability
09/21/2010US7799798 Spiroheterocyclic compounds and their uses as therapeutic agents
09/21/2010US7799797 (6-Benzenesulfonyl-naphthalen-1-ylmethyl)-methyl-amine, having a selective affinity for serotonin receptors, used for the treatment of nervous system disorders and gastrointestinal disorders; enhancing cognitive memory in a patient having Alzheimer's disease
09/21/2010US7799796 Diaminopyrimidines as P2X3 and P2X2/3 modulators
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010US7799794 Treatment for cardiovascular disease
09/21/2010US7799793 N-alkylated rifampin
09/21/2010US7799792 7-chloro-5-(5-piperazin-1-ylmethyl-[1,2,4]oxadiazol-3-yl)-2-(4-trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one, for the treatment of nervous system disorders and psychological disorders
09/21/2010US7799791 osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalemia, bone disorders, bone cancer, metastasis pain; e.g. N-(1-cyclopentyl-2-(6-methoxy-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)-2-oxoethyl)-4-(2-(4-methylpiperazin-1-yl)thiazol-4-yl)benzamide
09/21/2010US7799790 Morphological stabilized; using mixture of stabilizers
09/21/2010US7799789 treating chemokine mediated diseases; inflammatory, autoimmune diseases; graft rejection, rheumatoid arthritis, multiple sclerosis, psoriasis, ophthalmic inflammation, type I diabetes, viral meningitis
09/21/2010US7799788 Method of treating chronic myelogenous leukemia cells
09/21/2010US7799787 pyridazine derivatives such as N-(2-Cyclopropylethyl)-6-{4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl}pyridazine-3-carboxamide, useful for the prevention and treatment of dyslipidemia, obesity, diabetes, syndrome X, insulin resistance, fatty liver, cancer, cardiovascular and nervous system disorders
09/21/2010US7799786 Therapeutic agents useful for treating pain
09/21/2010US7799785 such as (4aS,13bR,14aR)-6-fluoro-1,4a,9,13b,14,14a-hexahydrodibenzo[3',4':6',7']-cyclohepta[1',2':4,5]pyrrolo[1,2-c]imidazole-3(2H)-thione, having binding affinities towards serotonin receptors, dopamine receptors and with norepinephrine reuptake inhibition properties; antidepressants; neuroleptic agents
09/21/2010US7799784 Quinoxaline derivatives of alpha-2 adrenergic agonists
09/21/2010US7799783 specifically 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil hydrochloride; breast cancer or digestive cancer; combination called TAS-102; modified dosing schedule
09/21/2010US7799782 P38 inhibitors and methods of use thereof
09/21/2010US7799781 5,6,7,8-tetrahydropteridine derivatives as HSP90 inhibitors
09/21/2010US7799780 4-(5,6-Dihydro-8H-imidazo[5,1-c][1,4]oxazin-8-yl)benzonitrile, used for the treatment of hypokalemia, hypertension, congestive heart failure, renal failure, restenosis, atherosclerosis, metabolic syndrome, obesity, hyperaldosteronism, nephropathy, myocardial infarction, edema and fibrosis
09/21/2010US7799779 5-[4-(3-Methoxypropyl)3.4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-4 -(4-phenoxyphenyl)-piperidin-3-ol, used for treating high blood pressure, glaucoma, myocardial infarction, restenoses or stroke
09/21/2010US7799778 5-substituted 2-aminopyridine analogs for treating allergic and inflammatory diseases
09/21/2010US7799777 Salts of potassium ATP channel openers and uses thereof
09/21/2010US7799776 taurine-substituted naphthaquinone derivatives, used for treating vision defects, neurodegenerative disorders, psychological disorders, cancer and bacterialor viral infections
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799774 Quinoline derivatives and their use as 5-HT6 ligands
09/21/2010US7799773 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans
09/21/2010US7799772 Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agents
09/21/2010US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate
09/21/2010US7799770 For use in female birth control, for therapy of hormone-dependent gynecological disorders and for hormone replacement therapy
09/21/2010US7799769 Daily dosage topical gel of an androgen with safe female-appropriate dose for side effect reduction; also for decreased sexual desire
09/21/2010US7799768 Polymorphs of 3-O-(3′,3′-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine
09/21/2010US7799766 Composition for treating hormonally-dependent cancers
09/21/2010US7799765 Association compound of trehalose or maltitol with metal ion compound
09/21/2010US7799764 hypoxia-inducible factors (HIFs); modified antisense oligonucleotide that inhibits expression of human HIF-1 beta; cancer, eye disorders
09/21/2010US7799763 Muscle-strengthening drugs and anti-inflammatory drugs
09/21/2010US7799762 Functionally substituted amino acids, having fatty acid chains bound through amidification of the amine functional groups of dipeptide like compounds, one end bears a functional side chain and other side neutral or charged acid
09/21/2010US7799755 Stimulating a Th2 response by administering multivalent LNFPIII, an immunomodulatory glycan Lacto-N-Fucopentaose III, which contains the Lewis X trisaccharide (CD!%/antigen/); autoimmune disease; antidiabetic agents; antiarthritic agents; multiple sclerosis; colitis; psoriasis
09/21/2010US7799565 Lipid encapsulated interfering RNA
09/21/2010US7799541 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction
09/21/2010US7799356 Prophylaxis or treatment of inflammatory skin conditions
09/21/2010US7799345 Preparation of injectable suspensions having improved injectability
09/21/2010US7799338 Plaster for topical use containing heparin and diclofenac
09/21/2010US7799337 Method for directed intranasal administration of a composition
09/21/2010US7799336 Hypotensive lipid-containing biodegradable intraocular implants and related methods
09/21/2010US7799335 Differential delivery of nitric oxide
09/21/2010US7799334 Pyrazolecarboxamides
09/21/2010US7799331 formulation comprising prednisolone acetate, a pharmaceutically acceptable vehicle and a thickening agent; endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, respiratory diseases, hemaologic disorders, neoplastic diseases, edema, gastrointestinal disease
09/21/2010US7799329 Viruses for the treatment of cellular proliferative disorders
09/21/2010US7799321 Color cosmetic compositions
09/21/2010CA2590575C 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands
09/21/2010CA2569549C Heat sterilization of glucocorticosteroids
09/21/2010CA2566945C Pyrazole derivatives, compositions containing such compounds and methods of use
09/21/2010CA2556185C A microemulsion preparation of high concentration propofol for anesthetic uses
09/21/2010CA2545821C Aroylfuranes and aroylthiophenes
09/21/2010CA2540822C Detection of no by using guanylyl cyclase and cgmp production as a readout system
09/21/2010CA2538884C Quinazoline derivatives as tyrosine kinase inhibitors
09/21/2010CA2521492C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
09/21/2010CA2513324C Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
09/21/2010CA2487165C Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
09/21/2010CA2481229C Substituted pyrazine inhibitors of akt
09/21/2010CA2477720C Quinoline derivatives
09/21/2010CA2473892C Novel quinoline derivatives
09/21/2010CA2470832C Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
09/21/2010CA2466770C Liquid pharmaceutical formulations of acetaminophen and an alkali metal 1-lactate salt
09/21/2010CA2458415C 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3
09/21/2010CA2451915C Crystalline composition containing escitalopram
09/21/2010CA2449521C Pharmaceutical formulation, its use, and method for its manufacture
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/21/2010CA2444123C Novel arylsulfonamides as antiviral agents
09/21/2010CA2441629C Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2438593C Glucopyranosyloxypyrazole derivatives and medicinal use thereof
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434308C Synthesis of temozolomide and analogs
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2433280C Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2428019C Estrogen receptor modulators
09/21/2010CA2420568C Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2416650C Enhancement of the action of central and peripheral nervous system agents
09/21/2010CA2414656C Pesticidal composition
09/21/2010CA2408746C Antisense phosporodiamidate morpholino oligonucleotide inhibition of cytochrome p450 to modulate drug pharmacokinetics
09/21/2010CA2405002C Antitumoral analogs of et-743
1 ... 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 ... 7860